External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ISPOR 2025
Roche and Genentech at

ISPOR 2025

May 13 - May 16
Montreal, Canada / Virtual (Hybrid)
ispor.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:00 PM
Duration 180mins Montreal, Canada
Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab▼ in HER2+ Early Breast Cancer Patients
Abbass IM, Behan E, Fung A, Patel A
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 180mins Montreal, Canada
The impact of family spillover effects in economic evaluation for SMA Type 1 treatments in the United States
Kowal S, Paffrath A, Cohen B, Shapouri S, McQueen R
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 60mins Montreal, Canada
Economic Impact of Multiplex Point-of-Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium: Development of a Modeling Framework
Susan N Chang
Infectious Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 180mins Montreal, Canada
Population Impact Model of Faricimab▼ and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Ko S, Bonine N, El Moustaid F, Rosettie K L, Meer E, Brodie F L
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 180mins Montreal, Canada
Evaluation of Real-World Total Healthcare Costs Difference Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab▼ in HER2+ Breast Cancer Patients
Patel A, Behan E, Fung A, Abbass IM
Oncology | Breast Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 150mins Montreal, Canada
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Pineda, Elmor D.; Rosettie, Kate; El Moustaid, Fadoua
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.